Close Menu
    Latest Category
    • Finance
    • Tech
    • EU Law
    • Energy
    • fx
    • About
    • Contact
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Login
    • EU News
    • Focus
    • Guides
    • Press
    • Jobs
    • Events
    • Directory
    EUbusiness.com | EU news, business and politicsEUbusiness.com | EU news, business and politics
    Home»pharma

    EC measures to tackle biopiracy and facilitate nature-based research

    eub2By eub24 October 2012 pharma No Comments4 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email
    — last modified 04 October 2012

    Researchers and companies in the EU received a boost today with a new proposal that should provide reliable access to genetic resources from outside the Union. The proposal – a draft Regulation that would implement the ‘Nagoya Protocol on Access to Genetic Resources and Benefit-sharing’ – is designed to protect the rights of countries and of indigenous and local communities that allow their genetic resources and associated traditional knowledge to be used, while also giving researchers in Europe improved, reliable access to quality samples of genetic resources at low cost with high legal certainty.


    Advertisement


    Genetic resources play a significant and growing role in many economic sectors, including plant and animal breeding, cosmetics and pharmaceuticals. Many of these resources come from biodiversity hotspots in the developing world. The Commission says that the absence of clear rules has led some countries to claim that their sovereign rights have been flouted by foreign researchers, a situation known as “biopiracy”. That lack of trust has occasionally led to restrictive conditions that hinder access to genetic resources. Today’s EC proposals are designed to address those fears, while maximizing opportunities for research, development and innovation in nature-based products and services. A level playing field for all EU users of genetic resources should bring particular benefits for SMEs and for publicly funded non-commercial research and enhance opportunities for international collaboration.

    The proposed Regulation would oblige users to check that genetic resources and associated traditional knowledge have been accessed in accordance with the applicable legal requirements in the country of origin, and that the benefits are fairly and equitably shared. Users would also be obliged to declare that they have exercised the “due diligence” required by the Regulation (or will do so in future). Users found in breach of the Regulation would be sanctioned.

    The Regulation also aims to help researchers and industry comply with the rules. Sectoral best practices will play an important role, and associations of users may request formal recognition of best practices on access and benefit-sharing, building on existing access and benefit-sharing codes of conduct for the academic sector and for different industries.

    An EU-register of trusted collections such as seed banks and botanical gardens would be established, identifying collections committed to supplying only fully documented samples of genetic resources. Users acquiring their research material from a trusted collection would be considered to have complied with most of the due diligence obligation. An EU platform would also be set up to streamline access conditions in Member States.

    Next Steps

    The proposed measures will now be considered by the European Parliament and the Council and once the text agreed, it will become EU law.

    The upcoming eleventh conference of the parties to the Convention on Biological Diversity in Hyderabad later this month will offer an important opportunity to explain the basic design of the legislative proposal and to continue collaboration with international partners for effective implementation of the Nagoya Protocol.

    Background

    Genetic resources are a vital input to numerous EU industries: 26% of all new approved drugs over the last 30 years, for example, are either natural products, or have been derived from a natural product.

    The Convention on Biological Diversity (CBD), of which the EU is a party, obliges signatories to facilitate access to genetic resources over which they hold sovereign rights, and to share in a fair and equitable way the results of research and development and the benefits arising from the commercial use of such resources. But the Convention provides little detail on how access and benefit-sharing should be done in practice, and industrialized countries have been reluctant to adopt measures supporting effective benefit-sharing. This has seriously undermined global progress to conserve and sustainably use biodiversity, which is unfortunate as ‘biodiversity-hotspots’ stand to gain the most from an effective ABS framework. The ‘Nagoya Protocol on Access to Genetic Resources and Benefit-sharing’ agreed in October 2010 filled many of these gaps, obliging signatories to take measures to ensure that only legally acquired genetic resources and associated traditional knowledge are utilized within their jurisdiction. The proposed Regulation provides the mechanism to put that obligation into practice in the European Union.

    Further information

    Source: European Commission

    Add A Comment

    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    eub2
    • Website

    eub2 is the default publisher for EUbusiness.

    Related Content

    Medicine Shortages in the EU – guide

    EU Commission agreement with BioNTech-Pfizer on the delivery of vaccines – guide

    Supplementary Protection Certificates – guide

    Proposal to ensure continued supply of medicines to Northern Ireland, as well as Cyprus, Ireland and Malta

    A Pharmaceutical Strategy for Europe – guide

    Supplementary protection certificate for medicinal products

    LATEST EU NEWS

    EU approves EUR 300m for common defence procurement projects

    14 November 2024

    EU proposes e-declaration for the posting of workers

    14 November 2024

    EU calls on Apple to end geo-blocking on media services

    14 November 2024

    EUR/USD touches one year low as Trump takes control of Congress – Euro currency news daily

    14 November 2024

    EU artificial intelligence factories set for 2025

    13 November 2024
    BRIEFING

    Agenda

    This week, COP29 begins in Azerbaijan; finance ministers discuss the EU's annual budget for 2025; and MEPs hold a plenary session on EU-US relations, EU summits, deforestation and COP 29...

    EUbusiness Week

    This week competitiveness and environment ministers will hold informal meetings…

    Eurozone Economic Calendar

    Key economic calendar events for the week 11 to 16 November 2024

    The Week's Top Stories

    This week competitiveness and environment ministers will hold informal meetings…

    Advertisement

    Subscribe to EUbusiness Week

    Get the latest EU news

    Latest Posts

    EU approves EUR 300m for common defence procurement projects

    14 November 2024

    EU proposes e-declaration for the posting of workers

    14 November 2024

    EU calls on Apple to end geo-blocking on media services

    14 November 2024

    EUR/USD touches one year low as Trump takes control of Congress – Euro currency news daily

    14 November 2024

    CONTACT INFO

    • EUbusiness Ltd 117 High Street, Chesham Buckinghamshire, HP5 1DE United Kingdom
    • +44(0)20 8058 8232
    • service@eubusiness.com

    INFORMATION

    • About Us
    • Advertising
    • Contact Info

    Services

    • Privacy Policy
    • Tems
    • EU News

    SOCIAL MEDIA

    Facebook
    eubusiness.com © EUbusiness Ltd 2025
    Design and developed by : Dotsquares

    Type above and press Enter to search. Press Esc to cancel.

    Sign In or Register

    Welcome Back!

    Login below or Register Now.

    Lost password?

    Register Now!

    Already registered? Login.

    A password will be e-mailed to you.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok